Skip to main content
ZURA logo

Zura Bio Limited

ZURANASDAQHealthcareBiotechnology

$3.88Today:- (-)1Y +33.33%

As of Oct 16, 2026 close

Market cap
$542.72M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.15$7.44
Volume (live)
-
Avg. volume (3M)
3.03M

Zura Bio (ZURA) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Zura Bio had return on equity of -52.5% (down from -43.8%), a current ratio of 9.05 (down from 9.16) and return on assets of -32.0% (down from -24.6%). A current ratio of 9.05 means current assets exceed current liabilities.

Zura Bio Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period endingDec 2025Dec 2024Dec 2023Mar 2022Dec 2021
Valuation Ratios
P/B Ratio3.361.022.5636.52-
Price/Tangible Book3.361.113.43--
Enterprise Value Ratios
Profitability & Returns
Return on Equity (ROE)-52.49%-43.75%-173.05%-5.22%
Return on Assets (ROA)-32.05%-24.60%-73.79%--0.63%
Return on Invested Capital (ROIC)-----0.64%
Return on Capital Employed (ROCE)-74.10%-34.50%-77.80%-1002.20%-0.63%
Leverage & Solvency Ratios
Debt/Equity----0.00
Liquidity Ratios
Current Ratio9.059.164.97121.034.23
Quick Ratio8.829.044.92121.032.68
Efficiency Ratios
Yield & Distribution Ratios
Earnings Yield-20.15%-32.10%-29.65%-27.44%-
FCF Yield-19.06%-17.25%-7.39%-0.98%-
Buyback Yield-25.43%-127.05%-14392.36%--

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Zura Bio Financial Ratios

What is Zura Bio's return on equity?

Zura Bio's return on equity (ROE) was -52.5% for fiscal 2025 (period ended Dec 31, 2025). It was -43.8% a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition